PROCEPT BioRobotics Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US74276L1052
USD
27.36
-0.63 (-2.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
TransMedics Group, Inc.
AtriCure, Inc.
iRhythm Technologies, Inc.
PROCEPT BioRobotics Corp.
Veracyte, Inc.
Integer Holdings Corp.
LivaNova Plc
NovoCure Ltd.
InMode Ltd.
STAAR Surgical Co.
Pacific Biosciences of California, Inc.

Why is PROCEPT BioRobotics Corp. ?

1
The company has declared Positive results for the last 7 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD -71.05 MM
  • NET PROFIT(HY) Higher at USD -40.99 MM
  • ROCE(HY) Highest at -27.22%
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -51.42%, its profits have risen by 15.4%
3
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Below par performance in long term as well as near term
  • Along with generating -51.42% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to PROCEPT BioRobotics Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is PROCEPT BioRobotics Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
PROCEPT BioRobotics Corp.
-53.65%
-1.01
58.94%
S&P 500
18.81%
0.98
19.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
81.63%
EBIT Growth (5y)
-35.87%
EBIT to Interest (avg)
-20.09
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.53
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.15
EV to EBIT
-14.46
EV to EBITDA
-15.48
EV to Capital Employed
9.58
EV to Sales
4.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-66.24%
ROE (Latest)
-22.24%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -71.05 MM

NET PROFIT(HY)

Higher at USD -40.99 MM

ROCE(HY)

Highest at -27.22%

NET SALES(Q)

Highest at USD 83.33 MM

RAW MATERIAL COST(Y)

Fallen by -3.19% (YoY

OPERATING PROFIT MARGIN(Q)

Highest at -25.89 %

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for PROCEPT BioRobotics Corp.

Operating Cash Flow
Highest at USD -71.05 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 83.33 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Net Profit
Higher at USD -40.99 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales
At USD 83.33 MM has Grown at 42.76%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit Margin
Highest at -25.89 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Raw Material Cost
Fallen by -3.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 1.62 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)